We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new shift in pharma company policy could shorten the time people in lower-income countries must typically wait for new medicines and vaccines, reports the 2021 Access to Medicine Index.